ReviewCanadian respiratory journal2026
Multiple Pulmonary Papillary Adenoma With Malignant Potential Accompanied by ERBIN-BRAF Gene Fusion and APC Mutation: A Case Report and Literature Review.
Review in Canadian respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiple Pulmonary Papillary Adenoma With Malignant Potential Accompanied by ERBIN-BRAF Gene Fusion and APC Mutation: A Case Report and Literature Review.Canadian respiratory journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary papillary adenoma is currently considered a benign tumor; however, a few cases have been reported in the past with potential for malignancy. Therefore, the histological nature of papillary adenomas remains controversial. This article presents a rare case of a multifocal papillary adenoma with uncertain malignant potential, featuring an ERBIN-BRAF gene fusion and an APC mutation, along with a literature review, to enhance understanding of this tumor. CASE DESCRIPTION: The patient sought medical consultation due to symptoms of cough and sputum production. Imaging showed a high-density, lobulated nodule in the posterior basal segment of the left lower lobe, surrounded by multiple smaller nodules. Postpulmonary lobectomy, histopathological examination revealed a large nodule composed of a single papillary structure, with the papillary surface covered by a single layer of cuboidal or low-columnar epithelium. Local areas showed transition to surrounding alveolar epithelium, and well-formed glands were observed in the proliferative fibrous tissue, with local stromal fibrosis. Some tumor cells in the surrounding small nodules grew in a lepidic fashion, with cellular morphology similar to that of the large nodule. Immunohistochemical staining showed that tumor cells were positive for TTF-1, CK, CK7, and Napsin A, with a few cells expressing P53 and a Ki-67 index of approximately 8%. Next-generation sequencing (NGS) identified an APC gene mutation (Exon 16, p.E1306∗) and an ERBIN exon3-BRAF exon11 fusion. Given that BRAF alterations have been implicated in lung carcinogenesis, a similar BRAF-mediated tumorigenic pathway may be active in this tumor; therefore, complete resection of the adenoma may be indicated. The tumor's multifocal distribution and molecular alterations suggest that this case represents a papillary adenoma with uncertain malignant potential.
conclusionsCurrently, there is no established standard treatment for such tumors, and the tumor in this case underwent pulmonary lobectomy. Future studies should accumulate more cases to clarify the prognosis and treatment guidelines for this type of tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.